Cargando…
RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy
BACKGROUND: MRIs of the brain in patients with short stature have shown a number of abnormalities. Some of these radiological findings can have clinical significance. Here we have looked at MRI results in such a population. OBJECTIVE: To review the value and significance of the prevalence of all abn...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625305/ http://dx.doi.org/10.1210/jendso/bvac150.1337 |
_version_ | 1784822460339716096 |
---|---|
author | Epstein, Benjamin McGuirk, Liam Krasnow, Matthew Manely, Sarah Sayegh, Emily Patale, Tara Schefflein, Javin Mehta, Hasit Mehta, Shilpa Tenner, Michael Noto, Richard |
author_facet | Epstein, Benjamin McGuirk, Liam Krasnow, Matthew Manely, Sarah Sayegh, Emily Patale, Tara Schefflein, Javin Mehta, Hasit Mehta, Shilpa Tenner, Michael Noto, Richard |
author_sort | Epstein, Benjamin |
collection | PubMed |
description | BACKGROUND: MRIs of the brain in patients with short stature have shown a number of abnormalities. Some of these radiological findings can have clinical significance. Here we have looked at MRI results in such a population. OBJECTIVE: To review the value and significance of the prevalence of all abnormal MRI findings of children with short stature who are to undergo growth hormone therapy (GHT). MATERIALS AND METHODS: This study involved a retrospective review of MRI findings in all children prescribed GHT within a pediatric health network's database from Jan 2020 to Aug 2021. Post-gadolinium contrast enhanced brain and pituitary MRIs utilizing 2 mm slices were used to calculate pituitary volume. Pituitary volume was calculated using the ellipsoid formula (LxWxH/2). Pediatric patients diagnosed with non-acquired GHD or ISS, with MRIs having been performed between Jan 2020 and Aug 2021 and having been prescribed GHT by Aug 2021 were included in this study. Patients who experienced other endocrine abnormalities such as SGA, Turner Syndrome, and Noonan Syndrome were excluded. Patients with obstruction of sellar and parasellar religion due to movement artifacts or magnetic interference on their MRIs were also excluded. RESULTS: Of one hundred and twelve patients found, eighty one met criteria for inclusion in this study. Of the eighty one MRIs reviewed, twenty eight children, 34.6%, had normal pituitary anatomy and fifty three, 65.4%, had a pituitary abnormality. Out of the fifty three with a pituitary abnormality, forty three subjects, 81.1%, were determined to have a small pituitary volume, including significant pituitary hypoplasia. Ten subjects (18.9%) had an enlarged pituitary volume (pituitary hyperplasia). Of these ten patients who had an enlarged pituitary volume, eight were pubertal (80%). Nine children with a pituitary abnormality (16.9%) had additional structural anomalies on their MRIs. One had a small left frontal developmental venous anomaly. Two had Rathke's cleft cysts. Two had pars intermedia cysts. One had a small right parietal developmental venous anomaly. One had a small left parietal developmental venous anomaly. One had a left cerebellar tonsillar ectopia bordering on chiari malformation (.5 mm away on the coronal plane). One had a small lobulation (semi-bulbous projection) of the anterior pituitary gland, superior and anterior to the infundibular stalk. CONCLUSION: Prevalence of brain abnormalities in children with short stature who are to undergo GHT is significant and warrants MRI evaluations in these subjects. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m., Monday, June 13, 2022 12:58 p.m. - 1:03 p.m. |
format | Online Article Text |
id | pubmed-9625305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96253052022-11-14 RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy Epstein, Benjamin McGuirk, Liam Krasnow, Matthew Manely, Sarah Sayegh, Emily Patale, Tara Schefflein, Javin Mehta, Hasit Mehta, Shilpa Tenner, Michael Noto, Richard J Endocr Soc Pediatric Endocrinology BACKGROUND: MRIs of the brain in patients with short stature have shown a number of abnormalities. Some of these radiological findings can have clinical significance. Here we have looked at MRI results in such a population. OBJECTIVE: To review the value and significance of the prevalence of all abnormal MRI findings of children with short stature who are to undergo growth hormone therapy (GHT). MATERIALS AND METHODS: This study involved a retrospective review of MRI findings in all children prescribed GHT within a pediatric health network's database from Jan 2020 to Aug 2021. Post-gadolinium contrast enhanced brain and pituitary MRIs utilizing 2 mm slices were used to calculate pituitary volume. Pituitary volume was calculated using the ellipsoid formula (LxWxH/2). Pediatric patients diagnosed with non-acquired GHD or ISS, with MRIs having been performed between Jan 2020 and Aug 2021 and having been prescribed GHT by Aug 2021 were included in this study. Patients who experienced other endocrine abnormalities such as SGA, Turner Syndrome, and Noonan Syndrome were excluded. Patients with obstruction of sellar and parasellar religion due to movement artifacts or magnetic interference on their MRIs were also excluded. RESULTS: Of one hundred and twelve patients found, eighty one met criteria for inclusion in this study. Of the eighty one MRIs reviewed, twenty eight children, 34.6%, had normal pituitary anatomy and fifty three, 65.4%, had a pituitary abnormality. Out of the fifty three with a pituitary abnormality, forty three subjects, 81.1%, were determined to have a small pituitary volume, including significant pituitary hypoplasia. Ten subjects (18.9%) had an enlarged pituitary volume (pituitary hyperplasia). Of these ten patients who had an enlarged pituitary volume, eight were pubertal (80%). Nine children with a pituitary abnormality (16.9%) had additional structural anomalies on their MRIs. One had a small left frontal developmental venous anomaly. Two had Rathke's cleft cysts. Two had pars intermedia cysts. One had a small right parietal developmental venous anomaly. One had a small left parietal developmental venous anomaly. One had a left cerebellar tonsillar ectopia bordering on chiari malformation (.5 mm away on the coronal plane). One had a small lobulation (semi-bulbous projection) of the anterior pituitary gland, superior and anterior to the infundibular stalk. CONCLUSION: Prevalence of brain abnormalities in children with short stature who are to undergo GHT is significant and warrants MRI evaluations in these subjects. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m., Monday, June 13, 2022 12:58 p.m. - 1:03 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625305/ http://dx.doi.org/10.1210/jendso/bvac150.1337 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Pediatric Endocrinology Epstein, Benjamin McGuirk, Liam Krasnow, Matthew Manely, Sarah Sayegh, Emily Patale, Tara Schefflein, Javin Mehta, Hasit Mehta, Shilpa Tenner, Michael Noto, Richard RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy |
title | RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy |
title_full | RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy |
title_fullStr | RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy |
title_full_unstemmed | RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy |
title_short | RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy |
title_sort | rf26 | psat109 the prevalence of abnormalities in cranial mris in children with short stature prior to growth hormone therapy |
topic | Pediatric Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625305/ http://dx.doi.org/10.1210/jendso/bvac150.1337 |
work_keys_str_mv | AT epsteinbenjamin rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT mcguirkliam rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT krasnowmatthew rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT manelysarah rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT sayeghemily rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT pataletara rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT scheffleinjavin rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT mehtahasit rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT mehtashilpa rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT tennermichael rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy AT notorichard rf26psat109theprevalenceofabnormalitiesincranialmrisinchildrenwithshortstaturepriortogrowthhormonetherapy |